Manhattan ResearchLantus (Sanofi-Aventis), Advair (GlaxoSmithKline), and Singulair (Merck) are the top pharmaceutical brand sites in terms of consumer visitor satisfaction, according to pharmaceutical and healthcare market research company Manhattan Research. The findings are from ePharma Consumer® v8.0, the company's latest study and strategic advisory service focused on how consumers find and use pharmaceutical resources online.

Other top brand sites leading in consumer satisfaction include Abilify (Bristol-Myers Squibb), Caduet (Pfizer), Januvia (Merck), Mirena (Bayer), Nexium/ (AstraZeneca), Prevacid (Takeda), and Protonix (Wyeth).

ePharma Consumer® v8.0 tracks consumer interaction with more than 250 branded and unbranded pharmaceutical sites, including in-depth data on the effect of DTC advertising, visitation, site search rationales, desired site tools and features, and actions taken off-site.

"Pharmaceutical marketing is rapidly evolving, and brand teams and agencies are looking beyond number of eyeballs to the site when evaluating their digital strategy. To truly understand online performance, marketers are focusing more on metrics such as engagement, action steps, satisfaction and of course conversions," said Mark Bard, president of Manhattan Research. "While driving visitors to sites is critical, engaging and retaining them will provide the most strategic value to the brand."

Complimentary Webinar - Monday, February 9, 2009
ePharma Consumer® v8.0: The Future of DTC Marketing

Manhattan Research President Mark Bard will preview the latest ePharma Consumer® data and trends for pharmaceutical marketers and agencies to make better-informed consumer marketing strategies. Mark will give insight into topics such as where and how consumers search for pharma info online; organic and paid search for pharma information; social networking and Web 2.0 applications; the corporate and product site landscape; and the role of a patient's condition in online behavior.

Session 1: Monday, February 9, 11:00 AM EST
Register here:

Session 2: Monday, February 9, 3:00 PM EST
Register here:

For assistance in signing up, please email your time preference to This email address is being protected from spambots. You need JavaScript enabled to view it. or call 212-255-7799.

About ePharma Consumer® v8.0
ePharma Consumer® v8.0 was conducted via online survey in Q4 2008 among 6,566 adults (age 18+). The study is focused on consumers online for pharmaceutical information. For additional product and subscription information, please visit

Some of the product sites covered in ePharma Consumer® include Abilify, Aciphex, Actonel, Advair, Ambien/Ambien CR, Aranesp, Aricept, Boniva, Botox, Caduet, Chantix, Cialis, Concerta, Crestor, Cymbalta, Depakote, Depo-Provera, Detrol LA, Effexor XR, Enbrel, Flomax, Flonase, Flovent, Fosamax, Gardasil, Humira, Imitrex, Lamisil, Lantus, Lexapro, Levitra, Lipitor, Lunesta, Nasacort, Nasonex, Neulasta, Neurontin, Nexium, Norvasc, NuvaRing, Ortho Evra, Ortho Tri-Cyclen Lo, Paxil, Plavix, Pravachol, Prevacid, Protonix, Provigil, Pulmicort, , Restasis, Risperdal, Rozerem, Seasonale, Seroquel, Singulair, Strattera, Tamiflu, Topamax, Toprol XL, TriCor, Valtrex, Viagra, Vytorin, Wellbutrin XL, Yasmin, Yaz, Zocor, Zoloft, Zomig, and Zyprexa.

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a leading market research and advisory services firm for global pharmaceutical and healthcare companies. For more information, visit

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at